In-silico study of approved drugs as potential inhibitors against 3CLpro and other viral proteins of CoVID-19. Aqeel I, Majid A, Alahmadi TJ, Althubaity A, et al. PLoS One 2025;20:e0325707.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aqeel I, Majid A, Alahmadi TJ, Althubaity A, et al. In-silico study of approved drugs as potential inhibitors against 3CLpro and other viral proteins of CoVID-19. PLoS One 2025;20:e0325707.
PMID: 40561178